Kona Medical

Kona Medical Develops Treatment to Alleviate the Suffering and Health Risks Associated with Resistant Hypertension. Kona Medical is committed to reducing the suffering and health risks associated with resistant hypertension through a more effective, minimally invasive renal artery denervation treatment. The company was founded in 2009 by Dr. Michael Gertner, with seed funding from Essex Woodlands. Kona Medical was established by combining Dr. Gertner’s innovative achievements in this field with the assets of Therus Corporation, a pioneer in therapeutic focused ultrasound.